NIIN Output Data
NIIN:
NSN:
Item Name:
THEOPHYLLINE EXTENDED-RELEASE CA
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| ELIXOPHYLLIN | 59463 | A | 5 | 1 | 6 | 54 | ||
| SLO-PHYLLIN GYROCAPS | 04518 | A | 5 | 1 | 6 | 54 | ||
| NDC50419-0123-51 | 59463 | A | 3 | 2 | 6 | 54 | ||
| NDC00067-1356-82 | 04518 | A | 3 | 2 | 6 | 54 |
CAGE Information
| Code | Company |
|---|---|
| 04518 | AVENTIS PHARMACEUTICALS PRODUCTS INC |
| 59463 | BAYER HEALTHCARE PHARMACEUTICALS INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| SUWT | UNIT OF ISSUE WEIGHT | 10.1250 POUNDS |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| EXQT | EXTERIOR CONTAINER QUANTITY | 6 |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 0.608 CUBIC FEET |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| FEAT | SPECIAL FEATURES | LONG ACTION METHOD:EXTENDED RELEASE; |
| SUCB | UNIT OF ISSUE CUBE | 0.6076 CUBIC FEET |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
| ECWT | EXTERIOR CONTAINER WEIGHT | 10.00 POUNDS |